The world moved a step closer to developing an enduring defence against AIDS after researchers in Thailand unveiled the results of a vaccine trial on Thursday that cut the risk of becoming infected with the HIV virus by nearly one-third and will not lead to secondary complications.
“These results have instilled new hope in the HIV vaccine research field and promise that a safe and highly effective HIV vaccine may become available for populations throughout the world who are most in need of such a vaccine,” said the statement issued by WHO and UNAIDS.
To accomplish its mission of increasing the health security of the U.S., the Centers for Disease...
A new COVID variant known as NB.1.8.1 has made landfall in the United States. The variant,...
